Saskia Braber

Title: Innovator Saskia Braber and Her Contributions to Mycotoxin Treatment

Introduction

Saskia Braber is a notable inventor based in Zeist, Netherlands. She has made significant contributions to the field of health and nutrition, particularly in the treatment of conditions associated with mycotoxin exposure. Her innovative work has led to the development of a unique composition aimed at alleviating the effects of harmful mycotoxins.

Latest Patents

Saskia Braber holds a patent for a composition that comprises a non-digestible oligosaccharide for the treatment, prevention, or alleviation of conditions associated with trichothecene mycotoxin exposure. This patent describes the use of non-digestible oligosaccharides, which may include galactooligosaccharides and/or fructooligosaccharides. Specifically, the composition may feature short chain galacto-oligosaccharides (scGOS) and/or short chain fructooligosaccharides (scFOS). The conditions targeted by this invention are particularly related to exposure to deoxynivalenol, a type of trichothecene mycotoxin.

Career Highlights

Saskia Braber is associated with N.V. Nutricia, a company known for its focus on nutritional products. Her work at Nutricia has allowed her to explore innovative solutions to health challenges, particularly those related to food safety and mycotoxin exposure.

Collaborations

Saskia has collaborated with esteemed colleagues such as Johan Garssen and Hermiena Christina Schoterman. These partnerships have contributed to the advancement of research in her field and have fostered a collaborative environment for innovation.

Conclusion

Saskia Braber's contributions to the treatment of mycotoxin exposure highlight her role as a pioneering inventor in the health and nutrition sector. Her innovative patent and collaborative efforts underscore the importance of addressing food safety challenges through scientific advancements.